A bone marrow test quote is more than one collection fee
A South Korean bone marrow aspiration or biopsy quote may separate collection, local anesthesia or sedation, needles and materials, basic smear and tissue pathology, flow cytometry, cytogenetics or FISH, molecular or genetic tests, and result visits.
This calculator keeps those stages visible, compares two provider itemizations, adds transport and caregiver time, and subtracts only an insurer-confirmed payout for the same full plan.
It is a booking budget, not a diagnosis, test recommendation, pathology interpretation, National Health Insurance adjudication, special-case registration decision, insurer decision, or provider ranking.
Every market amount starts at KRW 0.
The optional synthetic example validates the formula; it is not a Korean national average, fair price, or provider recommendation.
What the calculator includes
For each provider, the model first calculates the patient share of a gross covered charge using the rate confirmed by that provider billing office.
It then adds patient-paid collection, anesthesia or sedation, materials, basic pathology, consultation, medicines, recovery, and other medical items.
Additional pathology, flow cytometry, cytogenetics or FISH, and molecular or genetic testing remain separate, so a low collection quote cannot hide a large downstream laboratory budget.
Cash needed before reimbursement
Medical costs, result visits, transport, and caregiver time are combined before any confirmed insurance reimbursement is subtracted.
This is useful when an insurer pays after documents are submitted rather than on the collection date.
Household cost after confirmed insurance
Policy generation is stored only as a call note.
The model does not invent a reimbursement percentage and subtracts only the amount confirmed for the same codes, classifications, add-ons, and repeat scenario.
Add-on laboratory budget
Flow cytometry, cytogenetics or FISH, molecular or genetic work, and additional pathology are entered separately.
The calculator never determines which test is medically necessary or whether a particular item is covered.
Repeat collection and result visits
You can plan zero to two additional collection episodes and zero to three result visits.
A repeat is a conservative cash scenario using the same entered scope, not a forecast that another procedure will occur.
C8031 and C8520 are billing anchors, not patient prices
The January 2026 HIRA fee schedule lists `C8031` for bone marrow aspiration and `C8520` for unilateral bone marrow biopsy.
Their relative-value scores, 402.72 and 1,137.45, are not Korean won prices and are not a complete patient bill.
Provider type, care setting, benefit recognition, patient-share rules, simultaneous-procedure billing, pathology, and add-on laboratory items still matter.
HIRA 2026 bone marrow collection billing anchors| Procedure | Code | Relative-value score | Safe use in this calculator |
|---|
| Bone marrow aspiration | C8031 | 402.72 | Match the itemized procedure name and code |
| Unilateral bone marrow biopsy | C8520 | 1,137.45 | Confirm combined aspiration-and-biopsy billing |
If aspiration and biopsy are performed together
HIRA benefit criteria contain a billing rule for simultaneous aspiration and biopsy rather than a simple instruction to add two patient prices.
Ask the billing office which procedure names, codes, and patient amounts will appear on the itemization, then enter that confirmed quote.
The calculator intentionally does not convert the two scores into money or automatically add them.
Six budget stages to confirm
1. Collection
Confirm aspiration, biopsy, or both and the actual covered, non-covered, or full-self-pay patient amount.
2. Anesthesia and recovery
Confirm local anesthesia, sedation, recovery space, medicines, and whether each item is included.
3. Basic pathology
Check whether smear review and tissue pathology are bundled with collection or billed separately.
4. Add-on tests
List additional pathology, flow cytometry, cytogenetics or FISH, and molecular or genetic testing separately.
5. Result appointments
Budget the expected count and patient cost of visits used to explain results or plan next steps.
6. Household logistics
Add transport and caregiver time or replacement care for every collection and result visit.
Formula and synthetic comparison
Covered patient cost = gross covered charge × confirmed patient-share rate
Medical cost per collection = base collection medical cost + add-on tests
Medical cost before reimbursement = per-collection cost × collection count + result visits
Cash needed = pre-reimbursement medical cost + transport + caregiver cost
Household cost = medical cost − confirmed reimbursement + indirect cost
Only the gross covered charge is multiplied by a patient-share rate.
Every other medical field expects an amount already expressed as the patient payment, so multiplying it again would double count.
Reimbursement is capped at medical cost, and transport or caregiver time is not assumed to be reimbursable.
Synthetic provider A and B bone marrow test budget comparison| Budget item | Provider A | Provider B |
|---|
| Covered patient cost | KRW 120,000 | KRW 130,000 |
| Base collection medical cost | KRW 270,000 | KRW 380,000 |
| Add-on tests per collection | KRW 560,000 | KRW 650,000 |
| Result visit | KRW 25,000 | KRW 30,000 |
| Medical cost before reimbursement | KRW 855,000 | KRW 1,060,000 |
| Confirmed reimbursement applied | KRW 200,000 | KRW 250,000 |
| Transport and caregiver cost | KRW 100,000 | KRW 80,000 |
| Household cost after reimbursement | KRW 755,000 | KRW 890,000 |
In this synthetic vector, cash needed before reimbursement is KRW 955,000 for provider A and KRW 1,140,000 for provider B.
Household cost after the entered confirmed reimbursement is KRW 755,000 and KRW 890,000, a KRW 135,000 difference.
The difference is meaningful only when procedure, setting, anesthesia, add-ons, repeats, result visits, and all confirmations match.
Step-by-step use
- Match the clinical quote scope first.
Select aspiration, biopsy, or both; outpatient, day-procedure, or inpatient care; and the confirmed anesthesia or sedation plan for each provider.
- Separate a gross covered charge from patient-paid items.
Enter a billing-office-confirmed patient-share rate only for the gross covered charge.
Do not infer a five-percent special-case rate from the fact that a bone marrow test was ordered.
- Itemize laboratory add-ons.
Record the exact patient amount for additional pathology, flow cytometry, cytogenetics or FISH, and molecular or genetic testing.
- Include the result pathway.
Add result-visit cost, transport, and caregiver time for every planned collection and follow-up visit.
- Call the insurer with the same scope.
Provide procedure names, codes, covered or non-covered classifications, add-on names, setting, and repeat assumptions.
Enter only the total payout confirmed for that matching plan.
- Turn warnings into booking questions.
Resolve each code, simultaneous-billing, pathology, add-on, anesthesia, result-date, and inclusion warning before relying on the comparison.
Why the result reference shows one to two weeks or three to four weeks
The Korea Disease Control and Prevention Agency health portal says bone marrow test results generally take about one to two weeks and may take three to four weeks when genetic testing is included.
The calculator therefore displays a seven-to-fourteen-day general reference for basic scope and a twenty-one-to-twenty-eight-day reference when cytogenetic, FISH, molecular, or genetic scope is entered.
This is not a promised report date, appointment, medical deadline, or guarantee; specimen condition, outsourcing, laboratory workflow, and confirmatory work can change timing.
General reference: 7 to 14 days
This is the general portal range when extended genetic scope is not entered.
Always replace it with the date given by the collecting institution.
Extended reference: 21 to 28 days
This appears when cytogenetic, FISH, molecular, or genetic scope is selected or priced.
It does not mean every such test requires exactly four weeks.
Korean NHI, special-case registration, and out-of-pocket limits
National Health Insurance Act Articles 41 and 44, Enforcement Decree Article 19, and the Medical Care Benefit Rules create the covered-benefit, patient-share, and non-covered framework.
They do not create one universal bone marrow test price or one universal patient-share rate.
NHIS special-case registration follows physician confirmation and registration of a qualifying disease; an order for bone marrow testing is not itself a cancer diagnosis or automatic five-percent rate.
Non-covered, full-self-pay, and other excluded items are not automatically transformed into special-case or out-of-pocket-ceiling benefits.
- Ask whether this episode occurs before or after any qualifying registration and which items it affects.
- Confirm classification separately for collection, pathology, flow cytometry, cytogenetics, and molecular testing.
- Treat the displayed NHI share as arithmetic from the entered gross charge, not a claim-adjudication result.
- Do not assume the annual out-of-pocket ceiling refunds non-covered charges.
Useful comparison scenarios
Pathology is bundled differently
One provider may include basic pathology in collection while another lists it separately.
Compare matched line items rather than two top-line totals.
Sedation or admission changes the setting
An outpatient local-anesthesia quote is not equivalent to sedation with recovery or an inpatient quote.
Match setting and anesthesia before interpreting a lower amount.
Add-ons are conditional
If a clinician describes flow cytometry or genetic work as conditional, compare a confirmed minimum plan with a separate broader planning scenario.
Update the quote after the actual order is known.
Caregiver logistics matter
Sedation discharge or result discussions may require accompaniment.
Transport and caregiver time across all visits can exceed a small difference in medical fees.
Pre-booking checklist
- Confirm aspiration, biopsy, or both and the exact billing names and codes.
- Confirm how simultaneous aspiration and biopsy are represented on the itemization.
- Match outpatient, day-procedure, or inpatient setting and anesthesia, sedation, and recovery scope.
- Ask whether basic smear and tissue pathology are included or separately billed.
- List every additional pathology, flow-cytometry, cytogenetic, FISH, molecular, or genetic order and patient amount.
- Confirm covered, non-covered, or full-self-pay classification and the actual patient-share rate by item.
- Confirm the expected result date, result-visit count, and patient cost per visit.
- Give the insurer the same complete scope and ask for expected payment and required documents.
Frequently asked questions
Is there one national bone marrow test price in Korea?
No. Provider setting, procedure combination, anesthesia, pathology, add-ons, benefit recognition, registration, and individual patient share all matter. Enter an actual provider itemization.
Are aspiration and biopsy the same procedure?
They are complementary and are often performed together, but they collect different specimen types. The treating team determines the clinical scope; this tool only aligns budget scope.
Can I add the C8031 and C8520 scores to get a price?
No. Relative-value scores are not patient prices. Confirm simultaneous-procedure billing and actual patient-paid amounts with the provider.
Does a bone marrow test automatically qualify for the five-percent cancer rate?
No. A test order is not a cancer diagnosis or special-case registration. Confirm registration and item-level application with the billing office.
Does everyone need flow cytometry and genetic testing?
The calculator cannot decide that. Enter only tests ordered or quoted by the treating team and confirm each classification and amount.
Will results arrive exactly in two or four weeks?
No. Those are general KDCA portal ranges. Provider workflow, specimen status, outsourcing, and confirmatory work determine the actual date.
Does choosing a policy generation calculate reimbursement?
No. Generation is a call note. Enter only a payout the insurer confirmed for the same full plan.
Is a repeat count a medical prediction?
No. It is a zero-to-two conservative cash scenario using the same entered cost. Actual repeat scope requires a new clinical decision and quote.
Official sources and verification date
This guide was verified on August 25, 2026 using current Korean statutes and official agency material.
Statutes support the benefit, patient-share, and disclosure framework but do not adjudicate an individual claim or insurer payment.
- HIRA January 2026 fee schedule for C8031, C8520, and their relative-value scores.
- KDCA National Health Information Portal bone marrow test guide for complementary aspiration and biopsy, anesthesia context, and general result timing.
- NHIS special-case registration guide for registration, covered patient shares, and exclusions.
- HIRA non-covered medical price information as a starting point for provider item lookup.
- National Health Insurance Act ID 001971 and MST 276651 Articles 41 and 44; Enforcement Decree ID 002813 and MST 283469 Article 19; Medical Care Benefit Rules ID 006697 and MST 285513 Articles 5 and 9; and Medical Service Act ID 001788 and MST 285327 Articles 45 and 45-2 were checked through the National Law Information OPEN API.
Match inclusions before comparing totals
Ask both providers about the same collection, anesthesia, pathology, add-on, and result-visit scope, then enter actual patient-paid amounts.
Resolve every code, simultaneous-billing, pathology, add-on, and result-date warning before using the budget for booking.